This program will discuss how the increasing focus on women’s health issues will affect the drug and device industries. We will discuss:
- the history of neglect that has created the current crisis;
- the FDA’s new announced focus on women’s health issues and recent activities around breast implants, vaginal mesh, cosmetics, and other products;
- what companies developing products to be used by women need to know going forward; and
- how all this affects the potential benefit and risk profile for women’s health products.
General information on our practice is available in our electronic publications Serving the Life Sciences Industry and Serving the Healthcare Industry. If you would like to be included on our regular pharmaceutical manufacturers, medical device manufacturers or healthcare provider mailing lists to receive notices of other events and written updates, you can be added by submitting your full contact information to email@example.com and specifying the list you wish to join. If you have questions concerning this roundtable webinar, email firstname.lastname@example.org.
CLE credit will be applied for in CA, GA, IL, NY, TX and, if needed, NC and VA. Attendees will receive a Uniform Certificate of Attendance via email approximately 30 days after the program to seek CLE credit in other jurisdictions. New York lawyers: This program is considered transitional and non-transitional in content. The interactive webinar format is synchronous and approved for all lawyers. King & Spalding LLP | 1180 Peachtree Street NE, Atlanta, GA 30309 | CA Provider #10947.